- 서론
- 방법
- 결과
- 고찰
- 결론
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A60186829
2006
Korean
KCI등재,SCOPUS,SCIE
학술저널
447-452(6쪽)
0
0
상세조회0
다운로드참고문헌 (Reference)
1 Gibson KD, "Vascular access survival and incidence of revisions" 34 : 694-700, 2001
2 Kirkman BL, "Vascular access for hemodialysis" 235-9,
3 Fivush BA, "Vancomycin prevent polytetraflouroethylene graft infections in pediatric patients receiving chronic hemodialysis" 120-3,
4 Yu VL, "Staphylococcus aureus nasal carriage and infection in patients on hemodialysis Efficacy of antibiotic prophylaxis" 91-6,
5 Stevenson KB, "Standarized surveillance of hemodialysis vascular access infections" 21 : 200-203, 2000
6 Schild AF, "Single-center review of infections associated with 1,574 consecutive vascular access procedures" 37 : 27-31, 2003
7 Anderson JE, "Polytetraflouroethylene hemoaccess site infections" 46 : 18-21, 2000
8 Waltz P, "Partial excision of infected fistula results in increased patency at the cost of increased risk of recurrent infection" 19 : 84-89, 2005
9 Raju S, "PTFE grafts for hemodialysis access" 666-73,
10 Van Landuyt HW, "Nasal mupirocin ointment decreases incidence of Staphylococcus bacteremia in hemodialysis patients" 235-9,
1 Gibson KD, "Vascular access survival and incidence of revisions" 34 : 694-700, 2001
2 Kirkman BL, "Vascular access for hemodialysis" 235-9,
3 Fivush BA, "Vancomycin prevent polytetraflouroethylene graft infections in pediatric patients receiving chronic hemodialysis" 120-3,
4 Yu VL, "Staphylococcus aureus nasal carriage and infection in patients on hemodialysis Efficacy of antibiotic prophylaxis" 91-6,
5 Stevenson KB, "Standarized surveillance of hemodialysis vascular access infections" 21 : 200-203, 2000
6 Schild AF, "Single-center review of infections associated with 1,574 consecutive vascular access procedures" 37 : 27-31, 2003
7 Anderson JE, "Polytetraflouroethylene hemoaccess site infections" 46 : 18-21, 2000
8 Waltz P, "Partial excision of infected fistula results in increased patency at the cost of increased risk of recurrent infection" 19 : 84-89, 2005
9 Raju S, "PTFE grafts for hemodialysis access" 666-73,
10 Van Landuyt HW, "Nasal mupirocin ointment decreases incidence of Staphylococcus bacteremia in hemodialysis patients" 235-9,
11 Mailloux LU, "Mortality in dialysis patients analysis of the causes of death" 326-35,
12 Gifford RR, "Managment of tunnel infections of dialysis polytetraflouroethylene grafts" 854-8, jvascsurg1985
13 Bhat DJ, "Management of sepsis involving expanded polytetraflouroethylene grafts for hemodialysis access" 445-50, surg1980
14 Ryan SV, "Management of hemodialysis access infections" 17 : 40-44, 2004
15 Ballard JL, "Major complications of angioaccess surgery" 229-32, amjsurg1992
16 Nassar GM, "Infectious complications of the hemodialysis access" 60 : 1-13, 2001
17 Berman SJ, "Infections in patients with end-stage renal disease" 15 : 709-720, 2001
18 Deneuville M, "Infection of PTFE grafts used to create arteriovenous fistulas for hemodialysis access" 14 : 473-479, 2000
19 Taylor B, "Fate of infected and eroded hemodialysis grafts and autogenous fistula" 632-6, amjsurg1993
20 Hill SL, "Complications of dialysis access" 265-7, amjsurg1991
산발성 대장암에서 현미부수체 불안정성의 임상병리학적 의의
정맥 내 레이저 열 응고요법과 동시에 시행한 국소정맥류 절제술을 이용한 하지정맥류의 치료
학술지 이력
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2023 | 평가예정 | 해외DB학술지평가 신청대상 (해외등재 학술지 평가) | |
2020-11-12 | 학술지명변경 | 한글명 : 대한외과학회지 -> Annals of Surgical Treatment and Research | ![]() |
2020-01-01 | 평가 | 등재학술지 유지 (해외등재 학술지 평가) | ![]() |
2013-12-30 | 학술지명변경 | 외국어명 : Journal of The Korean Surgical Society -> Annals of Surgical Treatment and Research | ![]() |
2011-01-01 | 평가 | 등재학술지 유지 (등재유지) | ![]() |
2009-01-01 | 평가 | 등재학술지 유지 (등재유지) | ![]() |
2006-01-01 | 평가 | 등재학술지 선정 (등재후보2차) | ![]() |
2005-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) | ![]() |
2004-01-01 | 평가 | 등재후보학술지 유지 (등재후보1차) | ![]() |
2002-07-01 | 평가 | 등재후보학술지 선정 (신규평가) | ![]() |
학술지 인용정보
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 1.39 | 0.21 | 0.97 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
0.73 | 0.56 | 0.328 | 0.06 |